Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of central nervous system (CNS) active compounds. Its structure supports the creation of selective receptor modulators, including those targeting dopamine and serotonin receptors. Commonly found in research related to antidepressants, antipsychotics, and neurodegenerative disease treatments. The trifluoromethyl group enhances metabolic stability and bioavailability, making it valuable in medicinal chemistry for optimizing drug candidates. Also employed in agrochemical research for designing bioactive molecules with improved potency and resistance profiles.